Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_3
1
33%
Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Not yet recruiting1
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

not_yet_recruiting133%
completed133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

Effect of Intraperitoneal Insulin Administration After Laparoscopy in Insulin-Resistant Patients on Prevention of Postoperative Adhesion Recurrence: A Randomized Controlled Trial

NCT07007130
terminatednot_applicable

Management of Type 2 Diabetes After Gastric Bypass Surgery

NCT01213563
completedphase_3

Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)

NCT00135473

Clinical Trials (3)

Showing 3 of 3 trials
NCT07007130Not Applicable

Effect of Intraperitoneal Insulin Administration After Laparoscopy in Insulin-Resistant Patients on Prevention of Postoperative Adhesion Recurrence: A Randomized Controlled Trial

Not Yet Recruiting
NCT01213563Not Applicable

Management of Type 2 Diabetes After Gastric Bypass Surgery

Terminated
NCT00135473Phase 3

Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3